biomotiv accelerator company associated harrington project initiative centered university hospitals clevelandcitation needed therapeutic opportunities identified relationships harrington discovery institute university research institutions disease foundations industry sources opportunities identified biomotiv oversees development funding active management partnering therapeutic productscitation needed harrington project launched effort bridge varying aspects drug development sphere response recent decline number traditional earlystage biotechnology venture capital biomotiv utilizes assetcentric model inlicense fund manage technologies goal address valley death research discovery early clinicalstage drug development projects advanced management team clinical proofofconcept outlicensed via strategic alliances pharmaceutical company raised million date major investors include harrington family university hospitals takeda pharmaceutical arix charles river ron harrington biomotivs board managers chairman harrington projects lead led edgepark medical supplies growing business successfully sold company goldman sachs clayton dubilier rice renamed company assuramed sold cardinal health inc biomotiv recruited baiju shah former ceo bioenterprise nonprofit aimed boosting clevelands healthcare lead prior founding bioenterprise baiju worked mckinsey ted torphy biomotivs chief scientific officer prior biomotiv served global head external innovation business models discovery sciences vice president head external research early development corporate vice president head johnson johnsons corporate office science technology david c uprichard chairman advisory board served number biotechnology boards venture partner several funds chairman research development smithkline beecham biomotiv launched first subsidiary company orca pharmaceuticals based oxford england worked collaboration new york university innovation venture fund develop rarrelated orphan receptor gamma rory inhibitors treatments psoriasis ankylosing spondylitis inflammatory bowel disease today biomotivs subsidiary portfolio includes ten companies across five indication areas case western reserve university university washington cleveland clinic university pennsylvania biomotivs strategic partners include leaders drug development pharmaceutical industries well disease foundations september biomotiv entered first strategic partnership takeda pharmaceutical company areas immunology inflammation cardiometabolic today biomotiv four strategic partners httpsenwikipediaorgwikibiomotiv